Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Yu Lin

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Molecular Cell|April 9, 2011
Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulationChe-Chang Chang, Mandar T Naik, Yen-Sung Huang, et al.
Bioorganic Chemistry|March 16, 2020
Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitorsShu-Yu Lin, Chun-Feng Chang, Mohane Selvaraj Coumar, et al.
Journal of Medicinal Chemistry|December 8, 2015
Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1Yi-Hui Peng, Shau-Hua Ueng, Chen-Tso Tseng, et al.
Journal of Medicinal Chemistry|September 9, 2015
Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual ScreeningJian-Sung Wu, Shu-Yu Lin, Fang-Yu Liao, et al.
Journal of Medicinal Chemistry|February 7, 2023
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung CancerMu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, et al.
Journal of Medicinal Chemistry|September 28, 2019
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung CancerShu-Yu Lin, Yung Chang Hsu, Yi-Hui Peng, et al.
Cell Chemical Biology|July 18, 2024
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesiaYi-Han Huang, Shu-Yu Lin, Li-Chin Ou, et al.
Developmental Cell|March 29, 2025
KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubulesYuan-Shao Pao, Kuan-Ju Liao, Ya-Chia Shiau, et al.
Science (New York, N.Y.)|May 18, 2019
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathwayYu-Ru Lee, Ming Chen, Jonathan D Lee, et al.
Journal of Medicinal Chemistry|December 15, 2015
Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor EfficacyShu-Yu Lin, Teng-Kuang Yeh, Ching-Chuan Kuo, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Molecular Cell|April 9, 2011
Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulationChe-Chang Chang, Mandar T Naik, Yen-Sung Huang, et al.
Bioorganic Chemistry|March 16, 2020
Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitorsShu-Yu Lin, Chun-Feng Chang, Mohane Selvaraj Coumar, et al.
Journal of Medicinal Chemistry|December 8, 2015
Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1Yi-Hui Peng, Shau-Hua Ueng, Chen-Tso Tseng, et al.
Journal of Medicinal Chemistry|September 9, 2015
Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual ScreeningJian-Sung Wu, Shu-Yu Lin, Fang-Yu Liao, et al.
Journal of Medicinal Chemistry|February 7, 2023
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung CancerMu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, et al.
Journal of Medicinal Chemistry|September 28, 2019
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung CancerShu-Yu Lin, Yung Chang Hsu, Yi-Hui Peng, et al.
Cell Chemical Biology|July 18, 2024
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesiaYi-Han Huang, Shu-Yu Lin, Li-Chin Ou, et al.
Developmental Cell|March 29, 2025
KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubulesYuan-Shao Pao, Kuan-Ju Liao, Ya-Chia Shiau, et al.
Science (New York, N.Y.)|May 18, 2019
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathwayYu-Ru Lee, Ming Chen, Jonathan D Lee, et al.
Journal of Medicinal Chemistry|December 15, 2015
Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor EfficacyShu-Yu Lin, Teng-Kuang Yeh, Ching-Chuan Kuo, et al.
Pageof 12